Antiangiogenic proteins require plasma fibronectin or vitronectin for in vivo activity
Fragmentation of various extracellular matrix and blood proteins generates antiangiogenic substances that are physiological regulators of angiogenesis. Some of these compounds are in clinical trials as inhibitors of tumor angiogenesis. Anastellin, an antiangiogenic protein fragment derived from fibr...
Na minha lista:
| 發表在: | Proc Natl Acad Sci U S A |
|---|---|
| Principais autores: | , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
National Academy of Sciences
2003
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC208775/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/13679585/ https://ncbi.nlm.nih.govhttps://doi.org/10.1073/pnas.1635112100 |
| 標簽: |
沒有標簽, 成為第一個標記此記錄!
|